Champions Oncology Reports Quarterly Revenue of $12.0 Million [Yahoo! Finance]
Champions Oncology, Inc. (CSBR)
NASDAQ:AMEX Investor Relations:
championsoncology.com/investors
Company Research
Source: Yahoo! Finance
that offers end-to-end oncology solutions, today announced its financial results for its third quarter of fiscal 2024, ended January 31, 2024. Third Quarter and Recent Highlights: Third quarter revenue of $12.0 million, a decline of 6% Gross margin declined to 35% College of American Pathologists (CAP) has awarded accreditation to US-based laboratory Ronnie Morris, CEO of Champions, commented, "As discussed over the course of the year, we're navigating through a challenging economic environment, specifically in the biotech sector, that began approximately one year ago. However, we still remain confident that the tide is turning and we will emerge stronger over the coming quarters." Morris added, "We remain actively engaged with investors in an effort to raise capital for our wholly owned subsidiary, Corellia, AI. Conjunctively, our two lead targets continue to progress with the potential of a licensing deal in the coming quarters." David Miller, CFO of Champions, added, "I
Show less
Read more
Impact Snapshot
Event Time:
CSBR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSBR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSBR alerts
High impacting Champions Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
CSBR
News
- Will Champions Oncology (NASDAQ:CSBR) Spend Its Cash Wisely? [Yahoo! Finance]Yahoo! Finance
- Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Champions Oncology Reports Quarterly Revenue of $12.0 MillionAccesswire
- Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation [Yahoo! Finance]Yahoo! Finance
- Champions Oncology's US Laboratory has Acquired Distinguished CAP AccreditationAccesswire
CSBR
Earnings
- 12/12/23 - Beat
CSBR
Sec Filings
- 4/1/24 - Form 4
- 3/15/24 - Form 10-Q
- 3/12/24 - Form 8-K
- CSBR's page on the SEC website